Description: | Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite�s mitochondrial cytochrome�bc1�complex. Atovaquone is against human and �P. falciparum�cytochrome�bc1�activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia[1][2]. |